Genome Editing Market by Technology (CRISPR, TALEN, ZFN, Antisense, and Others), by Application (Cell Line Engineering, Genetic Engineering, and Others), and by End-User (Pharmaceutical & Biotechnological Companies, Academic and Research Institutes, and Contract Research Organizations)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020–2029
- TBI868096
- July 24, 2020
- Global
- 132 pages
- SAC Insights
Abstract
The report covers a forecast and an analysis of the genome editing market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the genome editing market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the genome editing market on a global level.
In order to give the users of this report a comprehensive view of the genome editing market, we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market.
The study provides a decisive view of the genome editing market by segmenting it on the basis of technology, application, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Some major players of the global genome editing market are Thermo Fisher Scientific, Transposagen Biopharmaceuticals, Horizon Discovery, Editas Medicine, GenScript, Integrated DNA Technologies, Sangamo BioSciences, Lonza Group, OriGene Technologies, Merck, New England Biolabs, and CRISPR Therapeutics.
This report segments the global genome editing market into:
Global Genome Editing Market: Technology Analysis
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)
TALEN (Transcriptor-Activator-Like Effector Nuclease)
ZFN (Zinc Finger Nucleases)
Antisense
Others
Global Genome Editing Market: Application Analysis
Cell Line Engineering
Genetic Engineering
Others
Global Genome Editing Market: End-User Analysis
Pharmaceutical and Biotechnological Companies
Academic and Research Institutes
Contract Research Organizations
Global Genome Editing Market: Regional Analysis
North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa
Table of Contents
Request Table Of Content
Click To Request Sample
Chapter 1. Introduction
1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
1.3.1. Market research process
1.3.2. Market research methodology
Chapter 2. Executive Summary
2.1. Global genome editing market, 2016-2025 (USD Billion)
2.2. Global genome editing market: Snapshot
Chapter 3. Genome Edi
| read more...
Related Reports
